Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
273 | 3 | P GLYCOPROTEIN//MULTIDRUG RESISTANCE//DRUG METABOLISM AND DISPOSITION | 43782 |
444 | 2 | CYTOCHROME P450//EPOXYEICOSATRIENOIC ACIDS//CYP2D6 | 16462 |
2390 | 1 | EPOXYEICOSATRIENOIC ACIDS//SOLUBLE EPOXIDE HYDROLASE//20 HYDROXYEICOSATETRAENOIC ACID | 2296 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | EPOXYEICOSATRIENOIC ACIDS | authKW | 3460800 | 14% | 80% | 316 |
2 | SOLUBLE EPOXIDE HYDROLASE | authKW | 2646084 | 10% | 84% | 229 |
3 | 20 HYDROXYEICOSATETRAENOIC ACID | authKW | 1200906 | 5% | 83% | 105 |
4 | 20 HETE | authKW | 1001028 | 4% | 75% | 97 |
5 | EETS | authKW | 621817 | 2% | 85% | 53 |
6 | CYP2J2 | authKW | 456793 | 2% | 79% | 42 |
7 | DIHYDROXYEICOSATRIENOIC ACID | authKW | 452926 | 1% | 100% | 33 |
8 | EPOXYGENASE | authKW | 391421 | 2% | 63% | 45 |
9 | SEH | authKW | 322753 | 1% | 87% | 27 |
10 | SOLUBLE EPOXIDE HYDROLASE INHIBITOR | authKW | 282337 | 1% | 86% | 24 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Peripheral Vascular Diseases | 6267 | 16% | 0% | 362 |
2 | Physiology | 4450 | 16% | 0% | 361 |
3 | Pharmacology & Pharmacy | 2338 | 20% | 0% | 469 |
4 | Biochemistry & Molecular Biology | 2182 | 28% | 0% | 649 |
5 | Cardiac & Cardiovascular System | 1161 | 10% | 0% | 229 |
6 | Cell Biology | 766 | 11% | 0% | 257 |
7 | Biophysics | 443 | 6% | 0% | 139 |
8 | Chemistry, Medicinal | 392 | 5% | 0% | 106 |
9 | Urology & Nephrology | 365 | 4% | 0% | 101 |
10 | Endocrinology & Metabolism | 286 | 6% | 0% | 127 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | UCD CANC | 151237 | 1% | 48% | 23 |
2 | UC DAVIS COMPREHENS CANC | 137028 | 1% | 37% | 27 |
3 | SW MED MOLEC GENET | 127653 | 1% | 47% | 20 |
4 | VASC SIGNALLING GRP | 114362 | 1% | 56% | 15 |
5 | INTRAMURAL | 111335 | 5% | 7% | 109 |
6 | ENTOMOL CANC | 74722 | 0% | 78% | 7 |
7 | UCD COMPREHENS CANC | 56024 | 1% | 29% | 14 |
8 | PULM PATHOBIOL | 55023 | 1% | 21% | 19 |
9 | VASC SIGNALLING | 54203 | 1% | 22% | 18 |
10 | KARDIOVASK PHYSIOL | 51487 | 1% | 22% | 17 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | 60999 | 4% | 5% | 92 |
2 | AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 9119 | 4% | 1% | 92 |
3 | HYPERTENSION | 8614 | 4% | 1% | 86 |
4 | ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH | 6893 | 1% | 3% | 20 |
5 | AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY | 5926 | 2% | 1% | 54 |
6 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 3635 | 3% | 0% | 76 |
7 | JOURNAL OF LIPID RESEARCH | 2470 | 2% | 0% | 40 |
8 | AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY | 2426 | 2% | 0% | 40 |
9 | PHARMACOGENETICS AND GENOMICS | 1967 | 1% | 1% | 13 |
10 | AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY | 1798 | 1% | 0% | 28 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | EPOXYEICOSATRIENOIC ACIDS | 3460800 | 14% | 80% | 316 | Search EPOXYEICOSATRIENOIC+ACIDS | Search EPOXYEICOSATRIENOIC+ACIDS |
2 | SOLUBLE EPOXIDE HYDROLASE | 2646084 | 10% | 84% | 229 | Search SOLUBLE+EPOXIDE+HYDROLASE | Search SOLUBLE+EPOXIDE+HYDROLASE |
3 | 20 HYDROXYEICOSATETRAENOIC ACID | 1200906 | 5% | 83% | 105 | Search 20+HYDROXYEICOSATETRAENOIC+ACID | Search 20+HYDROXYEICOSATETRAENOIC+ACID |
4 | 20 HETE | 1001028 | 4% | 75% | 97 | Search 20+HETE | Search 20+HETE |
5 | EETS | 621817 | 2% | 85% | 53 | Search EETS | Search EETS |
6 | CYP2J2 | 456793 | 2% | 79% | 42 | Search CYP2J2 | Search CYP2J2 |
7 | DIHYDROXYEICOSATRIENOIC ACID | 452926 | 1% | 100% | 33 | Search DIHYDROXYEICOSATRIENOIC+ACID | Search DIHYDROXYEICOSATRIENOIC+ACID |
8 | EPOXYGENASE | 391421 | 2% | 63% | 45 | Search EPOXYGENASE | Search EPOXYGENASE |
9 | SEH | 322753 | 1% | 87% | 27 | Search SEH | Search SEH |
10 | SOLUBLE EPOXIDE HYDROLASE INHIBITOR | 282337 | 1% | 86% | 24 | Search SOLUBLE+EPOXIDE+HYDROLASE+INHIBITOR | Search SOLUBLE+EPOXIDE+HYDROLASE+INHIBITOR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |